MedPath

Verification of the Safety of Normal Food Before a Cerebral Arteriography

Completed
Conditions
Cerebral Angiography
Registration Number
NCT04477031
Lead Sponsor
Nantes University Hospital
Brief Summary

Fasting is currently required before elective cerebral angiography, despite numerous arguments against fasting (kidney toxicity, vasovagal reaction, discomfort) and seams unusefull regarding it's main goal : reducing nausea and vomiting. The investigators propose to assess frequency of nausea and vomiting among patients having taken their breakfast at home before day care angiography.

The investigators hypothesise that less than 1% of non fasting patients will suffer of vomitint.

Detailed Description

Fasting is currently required before elective cerebral angiography, despite numerous arguments against fasting (kidney toxicity, vasovagal reaction, discomfort) and seams unusefull regarding it's main goal : reducing nausea and vomiting. The investigators propose to assess frequency of nausea and vomiting among patients having taken their breakfast at home before day care angiography.

The investigators hypothesise that less than 1% of non fasting patients will suffer of vomitint.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
677
Inclusion Criteria
  • Adult,
  • non fasting,
  • day care hosptilalisation
Exclusion Criteria
  • Childs,
  • pregnancy,
  • parenteral nutrition,
  • nausea,
  • vomiting before arteriography,
  • arteriography under general anesthesia

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
frequency of vomiting during arteriographic procedurefifteen minutes

The investigators check if there is vomiting or not during the examination noted by an electro radiology manipulator. Safety issue : Bronchus inhalation

Secondary Outcome Measures
NameTimeMethod
nauseafifteen minutes

The nausea will be evaluated using an analog visual scale (EVA) by an electro-radiology manipulator (MAR)at the exit of the intervention room

Trial Locations

Locations (1)

CHU de Nantes

🇫🇷

Nantes, France

CHU de Nantes
🇫🇷Nantes, France
Benjamin Daumas-Duport
Contact
02.40.16.56.11
benjamin.daumasduport@chu-nantes.fr
Benjamin Daumas-Duport, PH
Principal Investigator

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.